more frequent side effects
hypoglycemia
comprehensive list of adverse effects
needed effects
linagliptin
active ingredient
tradjenta
unwanted side effects
medical attention
following side effects
taking linagliptin
check
doctor
linagliptin side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
constipation
amylase levelsfrequency
pancreatitispostmarketing reports
acute pancreatitis
clinical trials
pancreatitis
cases
patient year exposure in patients
receiving linagliptin
cases
patient year exposure in those
receiving active comparator
sulfonylurea
following completion of clinical trials
additional cases of pancreatitis
receiving linagliptin
postmarketing reports of acute pancreatitis
including fatalities
common adverse event
nasopharyngitis
serious hypersensitivity reactions
anaphylaxis
angioedema
exfoliative skin conditions
been reported postmarketing in patients
drug
reactions
first months
occurring after the first dose
frequency
drug hypersensitivitypostmarketing reports
serious hypersensitivity reactions
hypoglycemia
hypertriglyceridemia
hyperlipidemia
uric acid
incidence of hypoglycemia in patients
drug as monotherapy
combination with metformin
pioglitazone
incidence
placebo-treated patients
combination with metformin
sulfonylurea
incidence of hypoglycemia
receiving placebo with metformin
sulfonylurea
stable insulin therapy
incidence of hypoglycemia
placebo
postmarketing reports of bullous pemphigoid
requiring hospitalization
dipeptidyl peptidase
inhibitors
case
systemic immunosuppressive treatment
discontinuation of dpp
inhibitor
postmarketing reports
rash
angioedema
urticariadipeptidyl peptidase
inhibitors
postmarketing reports
bullous pemphigoid
cough
nasopharyngitis
upper respiratory tract infection
october
december
cases of severe arthralgia
fda
adverse event reporting system database
case
use
more dipeptidyl peptidase
inhibitor
cases
substantial reduction in prior activity level
patients
disabling
disabling joint pain
cases
symptoms
month
starting therapy
cases symptoms
month after discontinuation
positive rechallenge
cases
cases
involving use of a different dpp
inhibitor
sitagliptin
greatest number of cases
n =-rrb-
saxagliptin
n =-rrb-
linagliptin
active ingredient
tradjenta
n =-rrb-
alogliptin
n =-rrb-
vildagliptin
n =-rrb-
pain
arthralgia
extremity pain
headache
urinary tract infection
side effects of tradjenta
fda
healthcare professional for medical advice
anxiety
blurred vision
chills
cold sweats
coma
confusion
cool, pale skin
depression
dizziness
fast heartbeat
headache
increased hunger
nausea
nightmares
seizures
shakiness
slurred speech
unusual tiredness
weakness
bloating
constipation
cough
fever
hives
welts
itching
skin rash
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
loss of appetite
pains in the stomach
side
abdomen
radiating
back
puffiness
swelling of the eyelids
eyes
face
lips
tongue
redness of the skin
severe joint pain
muscle aches
sore throat
runny nose
diarrhea